This page is dedicated to the Cerebrovascular Disorders research study, one of 57 studies supported by the Boston Children’s Rare Disease Collaborative (CRDC). For more information about the CRDC, please visit our home page. Established in 2018, the CRDC supports pediatric rare disease research and provides families with genetic diagnoses that enable personalized treatments, including precision medicine and targeted therapies.
The Cerebrovascular Disorders research study, established at Boston Children’s in 2022 and led by Drs. Siddharth Srivastava, Edward Smith, Darren Orbach, Katie Fehnel, Alfred See, and Laura Lehman, has already enrolled 35 patients and their families. The study aims to identify genetic causes of cerebrovascular disorders and provide personalized medicine.